Molecular Therapy - Methods & Clinical Development

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Molecular Therapy - Methods & Clinical Development
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Orphan Missense Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator  Fleur Fresquet, Romain Clement, Caroline Norez, Adélaïde Sterlin,
Molecular Therapy - Methods & Clinical Development
Volume 2, Issue 3, Pages (September 1998)
Deleterious impact of hyperglycemia on cystic fibrosis airway ion transport and epithelial repair  Claudia Bilodeau, Olivier Bardou, Émilie Maillé, Yves.
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel  Emanuela Pesce, Giulia Gorrieri,
Proliferation, Cell Cycle Exit, and Onset of Terminal Differentiation in Cultured Keratinocytes: Pre-Programmed Pathways in Control of C-Myc and Notch1.
Volume 15, Issue 8, Pages (May 2016)
A Role for DLK in Microtubule Reorganization to the Cell Periphery and in the Maintenance of Desmosomal and Tight Junction Integrity  Carolyne Simard-Bisson,
Ashley L Cooney, Brajesh K Singh, Patrick L Sinn  Molecular Therapy 
Volume 4, Issue 1, Pages (July 2001)
Molecular Therapy - Nucleic Acids
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Ambra Gianotti, Valeria Capurro, Paolo Scudieri, Luis J. V
Journal of Cystic Fibrosis
Ang II induces translocation of α-ENaC toward the apical membrane.
Molecular Therapy - Oncolytics
The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF  Paul D.W. Eckford, Jacqueline.
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation  Venkateshwar Mutyam,
Volume 18, Issue 10, Pages (October 2010)
Volume 85, Issue 5, Pages (May 2014)
Molecular Therapy - Methods & Clinical Development
Transduction of Human Embryonic Stem Cells by Foamy Virus Vectors
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking  Graeme W. Carlile, Renaud Robert, Julie Goepp, Elizabeth Matthes,
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Volume 65, Issue 5, Pages (May 2004)
Volume 19, Issue 1, Pages (January 2011)
Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi
A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae  Yang Wu, Liangyu Jiang,
Volume 20, Issue 1, Pages (January 2012)
Combination potentiator (‘co-potentiator’) therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators 
Volume 18, Issue 4, Pages (April 2010)
Volume 22, Issue 8, Pages (August 2014)
Molecular Therapy - Methods & Clinical Development
Volume 17, Issue 10, Pages (October 2009)
Molecular Therapy - Methods & Clinical Development
Volume 110, Issue 6, Pages (September 2002)
Prevention of Irradiation-induced Salivary Hypofunction by Microvessel Protection in Mouse Salivary Glands  Ana P Cotrim, Anastasia Sowers, James B Mitchell,
Volume 21, Issue 4, Pages (April 2013)
Generation of a stable packaging cell line producing high-titer PPT-deleted integration- deficient lentiviral vectors  Peirong Hu, Yedda Li, Mark S Sands,
Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo  Christian.
Volume 15, Issue 9, Pages (September 2007)
Volume 12, Issue 9, Pages (September 2015)
Volume 13, Issue 4, Pages (April 2013)
Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells
Volume 7, Issue 3, Pages (September 2016)
Md Nasimuzzaman, Danielle Lynn, Johannes CM van der Loo, Punam Malik 
Volume 17, Issue 12, Pages (December 2009)
Volume 102, Issue 5, Pages (March 2012)
Volume 18, Issue 3, Pages (March 2010)
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
Volume 6, Issue 3, Pages (September 2002)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 119, Issue 6, Pages (December 2000)
Volume 2, Issue 4, Pages (October 2000)
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors  Yani Hu,
Volume 20, Issue 4, Pages (April 2012)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Uta Griesenbach, A. Christopher Boyd  Journal of Cystic Fibrosis 
Engraftment of Bone Marrow–derived Stem Cells to the Lung in a Model of Acute Respiratory Infection by Pseudomonas aeruginosa  Joanna Rejman, Carla Colombo,
Presentation transcript:

Molecular Therapy - Methods & Clinical Development Testing gene therapy vectors in human primary nasal epithelial cultures  Huibi Cao, Hong Ouyang, Wan Ip, Kai Du, Wenming Duan, Julie Avolio, Jing Wu, Cathleen Duan, Herman Yeger, Christine E Bear, Tanja Gonska, Jim Hu, Theo J Moraes  Molecular Therapy - Methods & Clinical Development  Volume 2, (January 2015) DOI: 10.1038/mtm.2015.34 Copyright © 2015 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Primary culture of nasal epithelial cells results in a well-differentiated phenotype. Nasal cells were obtained by nasal brushing from non-cystic fibrosis (CF) human donor as described in methods. Epithelial cells were expanded in submerged cultures and then grown in air-liquid interface for 3 weeks. Cells imaged with confocal microscope. (a) Cross sectional view of human nasal epithelial cells demonstrating apical CFTR. Blue stain, DAPI (4’, 6-diamidino-2-phenylindole); red stain, β4 tubulin (cilia); green stain, CFTR protein. Bar indicates 10 µm. (b) Cross sectional view of human nasal epithelial cells demonstrating tight junctions. Blue stain, DAPI (looks purple); green stain, β4 tubulin (cilia); red stain, ZO1 (tight junctions). Bar indicates 20 µm. (c) Apical view of human nasal epithelial cells demonstrating cilia. Blue stain, DAPI; green stain, β4 tubulin (cilia). Bar indicates 10 µm. (d) Original Ussing trace from non-CF nasal cells displaying adequate bioelectric properties (Vte = −3.17 mV, Rte= 597 Ω cm2, Ieq = −5.31 µA/cm2) as well as functional expression of ENaC- and CFTR-mediated ion transport. CFTR, CF transmembrane conductance regulator; ENaC, epithelial sodium channel. Molecular Therapy - Methods & Clinical Development 2015 2, DOI: (10.1038/mtm.2015.34) Copyright © 2015 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Well-differentiated primary nasal epithelial cultures can be transduced with adenovirus expressing GFP. (a) GFP and (b) bright-field view of well-differentiated primary human nasal epithelial cells transduced at time of seeding onto semipermeable inserts with HD-Ad-GFP. Image was taken after 24 days of air-liquid interface culture. Panel (c) to (h) demonstrates GFP signal in WD-PNECs transduced with HD-Ad-GFP after 21 days in ALI culture. GFP expression was examined day 3 post-transduction. (c) Hundred viral particles per cell were used without any pretreatment. (d to f) Cells were pretreated with apical 6 mmol/l ethylene glycol tetraacetic acid (EGTA) prior to addition of (d) 100, (e) 1,000, and (f) 2,500 viral particles HD-Ad-GFP per cell. (g) and (h) were parallel experiments. Cells were pretreated with (g) 0.01% lysophosphatidylcholine or (h) 6 mmol/l EGTA. ALI, air liquid interface; HD-Ad-GFP, helper-dependent adenovirus expressing green fluorescent protein. Molecular Therapy - Methods & Clinical Development 2015 2, DOI: (10.1038/mtm.2015.34) Copyright © 2015 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Number of GFP expressing cells is related to dose of adenovirus vector. Representative scatter plots demonstrating gating of human nasal epithelial cells analyzed by flow cytometry after transduction. Side scatter and GFP signal as indicated. For these experiments, cells were apically transduced on day 21 of air liquid interface culture after pretreatment with ethylene glycol tetraacetic acid and studied on day 3 post-transduction. The three graphs show untransduced cells (control); cells transduced with 1,000 and 2,500 viral particles per cells as indicated. GFP-positive cells increase with higher vector dose. Molecular Therapy - Methods & Clinical Development 2015 2, DOI: (10.1038/mtm.2015.34) Copyright © 2015 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Apical expression of CFTR in cystic fibrosis (CF) cells postadenoviral transduction. (a) Human nasal epithelial cells from p.F508del/p.F508del CF patient in the absence of transduction and (b) post-transduction using HD-Ad-CFTR vector (2,500 viral particles per cell). Vector was added apically to cells after 21 days of air liquid interface culture and pretreatment with ethylene glycol tetraacetic acid. CFTR staining (green) is seen on the apical membrane of cells (white arrows). CFTR, CF transmembrane conductance regulator; DAPI, 4’, 6-diamidino-2-phenylindole. Molecular Therapy - Methods & Clinical Development 2015 2, DOI: (10.1038/mtm.2015.34) Copyright © 2015 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Functional expression of CFTR in human nasal epithelial cells (HNECs) following treatment HD-Ad-CFTR. Functional CFTR expression in HNEC measured in Ussing chamber studies. Original HNEC Ussing tracings from a CF patient (G480S/A559T) 72 hours after treatment. (a) HD-Ad-GFP or (b) HD-Ad-GFP. For panels (c) and (d), circles represent nontransduced cells, squares represent HD-Ad-CFTR transduced cells, and triangles represent HD-Ad-GFP-transduced cells. (c) Summary of CFTR function measured as Forskolin-activated current (Ieq-FSK) in HNEC from different CF patients, showed no change in CFTR function following treatment with HD-Ad-GFP (n = 4), but significant Ieq-FsK response following HD-Ad-CFTR (n = 7, P = 0.0017). (d) Similarly, the summary of CFTR function expressed as CFTRInh172 sensitive currents (Ieq CFTRInh172) showed no change with HD-Ad-GFP (n = 4), but significant increase in Ieq CFTRInh172 following HD-Ad-CFTR (n = 7, P < 0.001). CF, cystic fibrosis; CFTR, CF transmembrane conductance regulator; HD-Ad-GFP, helper-dependent adenovirus expressing green fluorescent protein. Molecular Therapy - Methods & Clinical Development 2015 2, DOI: (10.1038/mtm.2015.34) Copyright © 2015 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions